UK relatives of motor neurone disease patients are being offered genetic tests to assess their risk. Backed by Innovate UK, Sano Genetics provides this service to siblings and children of MND patients, with positive results offering counselling and clinical trial options. The initiative aims to expand genetic understanding and aid life planning for at-risk individuals.